The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery/indefinite quantity contract under the Safe Healthcare, Epidemiology, and Prevention Research Development Program to Duke University Office of Research Administration Division. With a potential value of $99 million and a period of performance through September 2026, this contract vehicle aims to procure epidemiological, behavioral and social science research and services across several domains including social determinants of health.
Two delivery orders have been awarded against this contract to date. The first is a firm fixed price order valued at $1.64 million with Duke University as the prime contractor to provide services supporting social determinants research from September 2022 through September 2024 in Durham, North Carolina. The second order awarded to Duke University for $476,968.88 leverages the National Healthcare Safety Network's Antibiotic Use Option for antibiotic stewardship initiatives from July 2022 through June 2023 in Rockville, Maryland. No set asides were applied to these awards.
The original solicitation sought epidemiological and prevention research development across social determinants of health, infectious disease analytics, healthcare-associated infections, antibiotic resistance and clinical prevention services to support the Centers for Disease Control and Prevention's public health mission. The task orders awarded to date indicate this indefinite delivery vehicle is being used to procure applied scientific research and subject matter expertise in furtherance of those goals.
Generated 1/4/24, 9:36 PM